Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Current Leases (2020 - 2026)

Cardiol Therapeutics filings provide 3 years of Current Leases readings, the most recent being $37164.5 for Q4 2022.

  • On a quarterly basis, Current Leases rose 4.78% to $37164.5 in Q4 2022 year-over-year; TTM through Dec 2022 was $37164.5, a 4.78% increase, with the full-year FY2022 number at $37164.5, up 4.78% from a year prior.
  • Current Leases hit $37164.5 in Q4 2022 for Cardiol Therapeutics, down from $37812.9 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $42468.6 in Q2 2021 to a low of $35468.5 in Q4 2021.
  • Median Current Leases over the past 3 years was $37813.0 (2022), compared with a mean of $38684.8.
  • The widest YoY moves for Current Leases: up 4.78% in 2022, down 10.96% in 2022.
  • Cardiol Therapeutics' Current Leases stood at $39821.6 in 2020, then fell by 10.93% to $35468.5 in 2021, then increased by 4.78% to $37164.5 in 2022.
  • The last three reported values for Current Leases were $37164.5 (Q4 2022), $37812.9 (Q3 2022), and $37813.1 (Q2 2022) per Business Quant data.